Latest Genentech Stories
Study Did Not Meet Primary or Key Secondary Endpoints SAN DIEGO, May 20, 2015 /PRNewswire/ -- Lpath, Inc.
LONDON, May 4, 2015 /PRNewswire/ -- Despite world-wide economic downturn and great changes in exchange rate, benefiting from robust market demand, global monoclonal antibody market size exceeded
SOUTH SAN FRANCISCO, Calif., April 22, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the election of veteran biopharmaceutical industry executive, Ronald A.
OXFORD, England, April 1, 2015 /PRNewswire/ -- Immunocore Limited ("the Company"), a world-leading biotechnology company developing novel biological drugs to treat cancer,
BISHOPS STORTFORD, England, March 26, 2015 /PRNewswire/ -- Customer Speakers Include AstraZeneca Neuroscience iMed, Genentech, Celgene and Many Others Dotmatics
300 Students to Receive Mentorships with Scientists from Top Research Institutions and Industry, and Financial Awards to Encourage Careers in Science and Cancer Research over Three Years
DALLAS, March 19, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Lucentis (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023" market research
RnRMarketResearch.com adds “Avastin (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023” to its store. Dallas, Texas (PRWEB)
SAN DIEGO, March 16, 2015 /PRNewswire/ -- Gensignia Life Sciences, Inc., (Gensignia) a molecular diagnostics company specializing in microRNA (miRNA) signatures as cancer diagnostic
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.